Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001936288-26-000004·Alvotech
Schedule 13D ownership disclosure
Alvotech SA
Ordinary Shares, nominal value of $0.01 per share · CUSIP: L01800108
Event date: 2025-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Aztiq Pharma Partners S.a r.l.Reported CIK 0001936288
Shares: 103,849,420.00 · Class: 33.3%
- Aztiq Fund I SCSp
Shares: 103,849,420.00 · Class: 33.3%
- Floki GP S.a r.l.
Shares: 103,849,420.00 · Class: 33.3%
- ATP ehf.
Shares: 3,003,290.00 · Class: 1.0%
- ATP Holdings ehf.
Shares: 3,020,861.00 · Class: 1.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001936288-26-000004
- Form type
- SCHEDULE 13D/A
- Filer
- Alvotech
- CIK
- CIK 1898416
- Filed
- Mar 12, 2026
- Reporting period
- Dec 17, 2025
- Description
- Schedule 13D beneficial ownership